CS logo
small CS logo
Fox Chase Cancer Center

Philadelphia, Pennsylvania, United States
Hospital in Philadelphia, Pennsylvania
333 Cottman Ave, Philadelphia, PA 19111

About Fox Chase Cancer Center


Fox Chase Cancer Center is a National Cancer Institute-designated Comprehensive Cancer Center research facility and hospital located in the Fox Chase section of Philadelphia, Pennsylvania, United States. The main facilities of the center are located on property adjoining Burholme Park.
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Fox Chase Cancer Center
169
National Cancer Institute (NCI)
134
Radiation Therapy Oncology Group
74
Gynecologic Oncology Group
63
Eastern Cooperative Oncology Group
59
SWOG Cancer Research Network
33
Alliance for Clinical Trials in Oncology
32
Pfizer
29
Bristol-Myers Squibb
25
ECOG-ACRIN Cancer Research Group
24
Hoffmann-La Roche
16
Total Rows: 100

Clinical Trials at Fox Chase Cancer Center


During the past decade, Fox Chase Cancer Center conducted 388 clinical trials. In the 10-year time frame, 388 clinical trials started and 347 clinical trials were completed, i.e. on average, 89.4% percent of trials that started reached the finish line to date. In the past 5 years, 110 clinical trials started and 171 clinical trials were completed. i.e. 155.5% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years4747616170705454464645454242232327273030474735353737363671714444Started TrialsCompleted Trails201520162017201820192020202120220255075
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment

Rows per page:

0–0 of 0

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Fox Chase Cancer Center" #1 sponsor was "Fox Chase Cancer Center" with 169 trials, followed by "National Cancer Institute (NCI)" with 134 trials sponsored, "Radiation Therapy Oncology Group" with 74 trials sponsored, "Gynecologic Oncology Group" with 63 trials sponsored and "Eastern Cooperative Oncology Group" with 63 trials sponsored. Other sponsors include 614 different institutions and companies that sponsored additional 263 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Fox Chase Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 421 trials as a collaborator, "NRG Oncology" with 57 trials as a collaborator, "Merck Sharp & Dohme LLC" with 28 trials as a collaborator, "Eastern Cooperative Oncology Group" with 19 trials as a collaborator and "Bristol-Myers Squibb" with 17 trials as a collaborator. Other collaborators include 436 different institutions and companies that were collaborators in the rest 224 trials.
Created with Highcharts 11.1.0Top Leading SponsorsFox Chase Cancer Center: 169Fox Chase Cancer Center: 169National CancerInstitute (NCI): 134National CancerInstitute (NCI): 134Radiation TherapyOncology Group: 74Radiation TherapyOncology Group: 74Gynecologic OncologyGroup: 63Gynecologic OncologyGroup: 63Eastern CooperativeOncology Group: 59Eastern CooperativeOncology Group: 59SWOG Cancer ResearchNetwork: 33SWOG Cancer ResearchNetwork: 33Alliance for ClinicalTrials in Oncology: 32Alliance for ClinicalTrials in Oncology: 32Pfizer: 29Pfizer: 29Bristol-Myers Squibb: 25Bristol-Myers Squibb: 25ECOG-ACRIN CancerResearch Group: 24ECOG-ACRIN CancerResearch Group: 24

Created with Highcharts 11.1.0Top CollaboratorsNational CancerInstitute (NCI): 421National CancerInstitute (NCI): 421NRG Oncology: 57NRG Oncology: 57Merck Sharp & Dohme LLC: 28Merck Sharp & Dohme LLC: 28Eastern CooperativeOncology Group: 19Eastern CooperativeOncology Group: 19Bristol-Myers Squibb: 17Bristol-Myers Squibb: 17SWOG Cancer ResearchNetwork: 17SWOG Cancer ResearchNetwork: 17Cancer and LeukemiaGroup B: 16Cancer and LeukemiaGroup B: 16Fox Chase Cancer Center: 14Fox Chase Cancer Center: 14North Central CancerTreatment Group: 14North Central CancerTreatment Group: 14Genentech, Inc.: 12Genentech, Inc.: 12

Clinical Trials Conditions at Fox Chase Cancer Center


According to Clinical.Site data, the most researched conditions in "Fox Chase Cancer Center" are "Prostate Cancer" (64 trials), "Breast Cancer" (51 trials), "Lung Cancer" (51 trials), "Head and Neck Cancer" (46 trials) and "Ovarian Cancer" (43 trials). Many other conditions were trialed in "Fox Chase Cancer Center" in a lesser frequency.

Clinical Trials Intervention Types at Fox Chase Cancer Center


Most popular intervention types in "Fox Chase Cancer Center" are "Drug" (852 trials), "Biological" (248 trials), "Other" (240 trials), "Radiation" (182 trials) and "Procedure" (167 trials). Other intervention types were less common.
The name of intervention was led by "Laboratory Biomarker Analysis" (96 trials), "radiation therapy" (66 trials), "paclitaxel" (58 trials), "Paclitaxel" (56 trials) and "cisplatin" (55 trials). Other intervention names were less common.

Clinical Trials Genders at Fox Chase Cancer Center


The vast majority of trials in "Fox Chase Cancer Center" are 874 trials for "All" genders, 171 trials for "Female" genders and 73 trials for "Male" genders.

Clinical Trials Status at Fox Chase Cancer Center


Currently, there are NaN active trials in "Fox Chase Cancer Center". undefined are not yet recruiting, 141 are recruiting, 192 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 613 completed trials in Fox Chase Cancer Center, 6 suspended trials, and 124 terminated clinical trials to date.
Out of the total trials that were conducted in Fox Chase Cancer Center, 266 "Phase 1" clinical trials were conducted, 538 "Phase 2" clinical trials and 284 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 92 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 2: 538Phase 2: 538Phase 3: 284Phase 3: 284Phase 1: 266Phase 1: 266Not Applicable: 92Not Applicable: 92Early Phase 1: 11Early Phase 1: 11Phase 4: 5Phase 4: 5

Created with Highcharts 11.1.0Trials StatusCompleted: 613Completed: 613Active, not recruiting: 192Active, not recruiting: 192Recruiting: 141Recruiting: 141Terminated: 124Terminated: 124Unknown status: 23Unknown status: 23Withdrawn: 14Withdrawn: 14Suspended: 6Suspended: 6Approved for marketing: 2Approved for marketing: 2Available: 2Available: 2No longer available: 1No longer available: 1

Departments of Fox Chase Cancer Center


Fox Chase Cancer Center has several departments that took part in Clinical trials: "Fox Chase Cancer Center - East Norriton Hospital Outpatient Center" - 22 trials, "Fox Chase Cancer Center Buckingham" - 21 trials, "Fox Chase Cancer Center" - 8 trials, "Fox Chase Cancer Center Extramural Research Program" - 4 trials, "Fox Chase Cancer Center; Hematology/Oncology" - 3 trials, "Fox Chase Cancer Center 333 Cottman Avenue" - 2 trials